Caring for Survivors of Gynecologic Cancer: Assessment and Management of Long-term and Late Effects

1986, History of NCCS, Charter 2017, Chapter 7. Survivorship and rehabilitation: policy recommendations for quality improvement in cancer survivorship and rehabilitation in EU Member States, 135 American Cancer Society. Cancer treatment and survivorship facts and figures 2016-2017. Atlanta, GA; 2017. Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2016-2017.pdf. Miller, 2016, Cancer treatment and survivorship statistics, 2016, CA Cancer J Clin, 66, 271, 10.3322/caac.21349 Mullan, 1985, Seasons of survival: reflections of a physician with cancer, N Engl J Med, 313, 270, 10.1056/NEJM198507253130421 Hewitt, 2005 Richards, 2011, The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors, Br J Cancer, 105, S1, 10.1038/bjc.2011.416 Hardy, 2011, Ability to walk 1/4 mile predicts subsequent disability, mortality, and health care costs, J Gen Intern Med, 26, 130, 10.1007/s11606-010-1543-2 Klugel, 2017, Concomitant psychiatric symptoms and impaired quality of life in women with cervical cancer: a critical review, Int J Womens Health, 9, 795, 10.2147/IJWH.S143368 Wen, 2017, Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy, Eur J Obstet Gynecol Reprod Biol, 216, 85, 10.1016/j.ejogrb.2017.07.004 Ramsey, 2016, Financial insolvency as a risk factor for early mortality among patients with cancer, J Clin Oncol, 34, 980, 10.1200/JCO.2015.64.6620 National Cancer Institute. Financial toxicity and cancer treatment (PDQ)–health professional version. Available at: https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-hp-pdq. (Accessed 6 February 2018). 2016 Salani, 2013, Survivorship planning in gynecologic cancer patients, Gynecol Oncol, 130, 389, 10.1016/j.ygyno.2013.05.022 2001, Cervical cancer, Pract Guidel Oncol 2001, Uterine Neoplasms, Pract Guidel Oncol, 1 Stubblefield, 2009, NCCN Task Force Report: management of neuropathy in cancer, J Natl Compr Cancer Netw, 7, 1, 10.6004/jnccn.2009.0078 1987, Ovarian cancer, Pract Guidel Oncol, 11, 57 Salani, 2017, An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations, Gynecol Oncol, 146, 3, 10.1016/j.ygyno.2017.03.022 Pearson-Stuttard, 2018, Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment, Lancet Diabetes Endocrinol, 6, e6, 10.1016/S2213-8587(18)30150-5 McTiernan, 2010, Weight, physical activity, diet, and prognosis in breast and gynecologic cancers, J Clin Oncol, 28, 4074, 10.1200/JCO.2010.27.9752 Arem, 2013, Obesity and endometrial cancer survival: a systematic review, Int J Obes, 37, 634, 10.1038/ijo.2012.94 Stevinson, 2009, Physical activity in ovarian cancer survivors: Associations with fatigue, sleep, and psychosocial functioning, Int J Gynecol Cancer, 19, 73, 10.1111/IGC.0b013e31819902ec Smits, 2015, Body mass index, physical activity and quality of life of ovarian cancer survivors: time to get moving?, Gynecol Oncol, 139, 148, 10.1016/j.ygyno.2015.08.005 Rock, 2012, Nutrition and physical activity guidelines for cancer survivors, CA Cancer J Clin, 62, 242, 10.3322/caac.21142 Thomson, 2016, A randomized trial of diet and physical activity in women treated for stage II–IV ovarian cancer: rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) study, Contemp Clin Trials, 49, 181, 10.1016/j.cct.2016.07.005 Waggoner, 2006, Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study, Gynecol Oncol, 103, 853, 10.1016/j.ygyno.2006.05.017 Bellizzi, 2005, Health behaviors of cancer survivors: examining opportunities for cancer control intervention, J Clin Oncol, 23, 8884, 10.1200/JCO.2005.02.2343 Burke, 2009, Smoking behaviors among cancer survivors: an observational clinical study, J Oncol Pract, 5, 6, 10.1200/JOP.0912001 Westin, 2016, Survivors of gynecologic malignancies: impact of treatment on health and well-being, J Cancer Surviv, 10, 261, 10.1007/s11764-015-0472-9 Grover, 2012, Patient reported late effects of gynecological cancer treatment, Gynecol Oncol, 124, 399, 10.1016/j.ygyno.2011.11.034 Donovan, 2014, Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials, J Natl Cancer Inst, 106, 10, 10.1093/jnci/dju128 Beesley, 2013, Changes in supportive care needs after firstline treatment for ovarian cancer: identifying care priorities and risk factors for future unmet needs, Psychooncology, 22, 1565, 10.1002/pon.3169 Beesley, 2008, Unmet needs of gynecological cancer survivors: implications for developing community support services, Psychooncology, 17, 392, 10.1002/pon.1249 Urbaniec, 2011, Gynecological cancer survivors: assessment of psychological distress and unmet supportive care needs, J Psychosoc Oncol, 29, 534, 10.1080/07347332.2011.599829 Hodgkinson, 2007, Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes, Gynecol Oncol, 104, 381, 10.1016/j.ygyno.2006.08.036 Carter, 2010, Cancer-related infertility in survivorship, Int J Gynecol Cancer, 20, 2, 10.1111/IGC.0b013e3181bf7d3f Hamilton, 2009, Living with genetic test results for hereditary breast and ovarian cancer, J Nurs Scholarsh, 41, 276, 10.1111/j.1547-5069.2009.01279.x Daley, 2015, Negative emotions and stigma associated with a human papillomavirus test result: a comparison between human papillomavirus-positive men and women, J Health Psychol, 20, 1073, 10.1177/1359105313507963 Jones, 2012, Experiences of care delivery: endometrial cancer survivors at end of treatment, Gynecol Oncol, 124, 458, 10.1016/j.ygyno.2011.10.037 Ferrandina, 2012, Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study, Gynecol Oncol, 124, 389, 10.1016/j.ygyno.2011.09.041 Bifulco, 2012, Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers, Gynecol Oncol, 124, 444, 10.1016/j.ygyno.2011.11.033 von Gruenigen, 2009, A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change, Health Qual Life Outcomes, 7, 1, 10.1186/1477-7525-7-17 Abbott-Anderson, 2012, A systematic review of sexual concerns reported by gynecological cancer survivors, Gynecol Oncol, 124, 477, 10.1016/j.ygyno.2011.11.030 Mirabeau-Beale, 2009, Comparison of the quality of life of early and advanced stage ovarian cancer survivors, Gynecol Oncol, 114, 353, 10.1016/j.ygyno.2009.05.009 Carter, 2018, Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation of cancer care Ontario guideline, J Clin Oncol, 36, 492, 10.1200/JCO.2017.75.8995 Cormier, 2010, Lymphedema beyond breast cancer, Cancer, 116, 5138, 10.1002/cncr.25458 Hareyama, 2015, Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies, Int J Gynecol Cancer, 25, 751, 10.1097/IGC.0000000000000405 Lockwood-Rayermann, 2007, Lymphedema in gynecologic cancer survivors, Cancer Nurs, 30, E11, 10.1097/01.NCC.0000281734.48479.33 Holloway, 2017, Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations, Gynecol Oncol, 146, 405, 10.1016/j.ygyno.2017.05.027 Cemal, 2013, Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema, Lymphat Res Biol, 11, 14, 10.1089/lrb.2012.0015 Ramaseshan, 2017, Pelvic floor disorders in women with gynecologic malignancies: a systematic review, Int Urogynecol J, 29, 459 Fernandes, 2015, Management of toxicities following pelvic irradiation for gynaecological cancers, Curr Opin Oncol, 27, 405, 10.1097/CCO.0000000000000215 Rutledge, 2017, Pevic floor disorders and sexual function in gyneclogic cancer survivors: a cohort study, Am J Obstet Gynecol, 203, 1 Langenberg, 2010, Pelvic pain and surgeries in women before interstitial cystitis/painful bladder syndrome, Am J Obstet Gynecol, 202, 286, 10.1016/j.ajog.2009.10.866 Payne, 2013, Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges, BJU Int, 112, 885 Andreyev, 2013, Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial, Lancet, 382, 2084, 10.1016/S0140-6736(13)61648-7 Kuku, 2013, Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers, Br J Cancer, 109, 1504, 10.1038/bjc.2013.491 Sang, 2007, Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population, Cancer, 110, 2716, 10.1002/cncr.23094 Andreyev, 2012, Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer, Gut, 61, 179, 10.1136/gutjnl-2011-300563 Benton, 2011, Can nurses manage gastrointestinal symptoms arising from pelvic radiation disease?, Clin Oncol, 23, 538, 10.1016/j.clon.2011.03.006 Teo, 2015, Prevention and management of radiation-induced late gastrointestinal toxicity, Clin Oncol, 27, 656, 10.1016/j.clon.2015.06.010 Teo, 2018, The relationship between symptom prevalence, body image, and quality of life in Asian gynecologic cancer patients, Psychooncology, 27, 69, 10.1002/pon.4457 Vistad, 2011, A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer, J Cancer Surviv, 5, 208, 10.1007/s11764-011-0172-z Pachman, 2012, Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain, J Clin Oncol, 30, 3687, 10.1200/JCO.2012.41.7238 Correa, 2012, Cognitive function and quality of life in ovarian cancer, Gynecol Oncol, 124, 404, 10.1016/j.ygyno.2011.11.005 Van Arsdale, 2016, Prevalence and factors associated with cognitive deficit in women with gynecologic malignancies, Gynecol Oncol, 141, 323, 10.1016/j.ygyno.2016.03.001 Hess, 2010, Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer, J Support Oncol, 8, 252, 10.1016/j.suponc.2010.09.028 de Ruiter, 2011, Cerebral hyporesponsiveness and cognitive impairment 10years after chemotherapy for breast cancer, Hum Brain Mapp, 32, 1206, 10.1002/hbm.21102 Kreukels, 2008, Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer, Clin Breast Cancer, 8, 80, 10.3816/CBC.2008.n.006 Cavaletti, 2015, Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?, Am Soc Clin Oncol Educ B, 35, e553, 10.14694/EdBook_AM.2015.35.e553 Mols, 2015, Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry, J Cancer Surviv, 9, 512, 10.1007/s11764-015-0427-1 Ezendam, 2014, Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry, Gynecol Oncol, 135, 510, 10.1016/j.ygyno.2014.09.016 Tanay, 2017, The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis, Eur J Cancer Care (Engl), 26, 10.1111/ecc.12443 Park, 2013, Chemotherapy-induced peripheral neurotoxicity: a critical analysis, CA Cancer J Clin, 63, 419, 10.3322/caac.21204 Campbell, 2016, Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: a cross-sectional study, Gynecol Oncol, 143, 578, 10.1016/j.ygyno.2016.09.013 Avan, 2015, Platinum-induced neurotoxicity and preventive strategies: past, present, and future, Oncologist, 20, 411, 10.1634/theoncologist.2014-0044 Smith, 2013, Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial, JAMA, 309, 1359, 10.1001/jama.2013.2813 Otake, 2015, Usefulness of duloxetine for paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients, Anticancer Res, 35, 359 Aziz, 2014, Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy, Ann Pharmacother, 48, 626, 10.1177/1060028014525033 Duregon, 2018, Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: a systematic review, Crit Rev Oncol Hematol, 121, 90, 10.1016/j.critrevonc.2017.11.002 Hershman, 2014, Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline, J Clin Oncol, 32, 1, 10.1200/JCO.2013.54.0914 Birken, 2014, Potential determinants of health-care professionals’ use of survivorship care plans: a qualitative study using the theoretical domains framework, Implement Sci, 9, 167, 10.1186/s13012-014-0167-z Mayer, 2015, Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013), Cancer, 121, 978, 10.1002/cncr.28884 de Rooij, 2018, Survivorship care plans have a negative impact on long-term quality of life and anxiety through more threatening illness perceptions in gynecological cancer patients: the ROGY care trial, Qual Life Res, 27, 1533, 10.1007/s11136-018-1825-4 de Rooij, 2017, Effects of survivorship care plans on patient reported outcomes in ovarian cancer during 2-year follow-up – the ROGY care trial, Gynecol Oncol, 145, 319, 10.1016/j.ygyno.2017.02.041 Nekhlyudov, 2017, Going beyond being lost in transition: a decade of progress in cancer survivorship, J Clin Oncol, 35, 1978, 10.1200/JCO.2016.72.1373 Bluethmann, 2016, Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States, Cancer Epidemiol Biomarkers Prev, 25, 1029, 10.1158/1055-9965.EPI-16-0133 Varughese, 2010, Cancer care inequity for women in resource-poor countries, Rev Obstet Gynecol, 3, 122